Publications by authors named "S Heidari"
Beyond COVID-19, the case for collecting, analysing and using sex-disaggregated data and gendered data to inform outbreak response: a scoping review.
BMJ Glob Health
January 2025
Introduction: Understanding sex and gender differences during outbreaks is critical to delivering an effective response. Although recommendations and minimum requirements exist, the incorporation of sex-disaggregated data and gender analysis into outbreak analytics and response for informed decision-making remains infrequent. A scoping review was conducted to provide an overview of the extent of sex-disaggregated data and gender analysis in outbreak response within low- and middle-income countries (LMICs).
View Article and Find Full Text PDFIntroduction: Organ transplant recipients face a substantial risk of developing posttransplant lymphoproliferative disorders (PTLD). In over 90% of cases with B-cell PTLD following solid organ transplantation, the Epstein-Barr virus (EBV) genome is promptly identified, usually within the initial year. A continuing discussion revolves around the efficacy of antiviral prophylaxis in mitigating the incidence of PTLD in solid organ transplant (SOT) patients.
View Article and Find Full Text PDFArticle Synopsis
- The JBJS symposium focused on the importance of including sex and gender in orthopaedic research to enhance study methods and patient outcomes, addressing current shortcomings in reporting.
- Barriers to proper reporting stem from cultural resistance, inadequate education on terminology and study design, insufficient funding for larger studies, and the need for better understanding of how biological and social factors like gender and race interact in health research.
- To overcome these challenges, the development of best-practice statistical methods and ongoing education for all stakeholders in research is crucial, with existing guidelines like the SAGER providing a framework for improvement and support from academic institutions and funders being essential for meaningful progress.
People with HIV (PWH) and people with diabetes mellitus have increased risk of severe COVID-19, but little is known about humoral response to COVID-19 vaccines in PWH with DM. We investigated SARS-CoV-2 antireceptor-binding domain (anti-RBD) immunoglobulin G (IgG) geometrical concentrations and neutralizing antibody capacity (nAB) in PWH with and without diabetes mellitus. Anti-RBD IgG and nAB in COVID-19-vaccinated PWH were not associated with diabetes mellitus-status or HbA1c 24 months after the initial COVID-19 vaccination.
View Article and Find Full Text PDF